• Maintained solid financial position with healthy cash balance and prudent cost control
• Significant commercial momentum with new client wins and expanded deployments with existing clients
• Drove product innovation, including launch of AI-powered care assistant 'Ovie' and enhanced digital patient experiences

The CEO of Oneview Healthcare delivered a comprehensive update on the company's achievements in 2025 and its outlook for 2026. Oneview maintained a solid financial foundation, with a healthy cash position and prudent cost control. The company saw significant commercial momentum, adding new healthcare system clients in the US and expanding deployments with existing customers. Key highlights included the launch of the AI-powered care assistant 'Ovie' and enhancements to the digital patient experience. While facing some challenges in the Australian private hospital sector, Oneview responded with strategic reorganization and remained vigilant to macro-economic factors. Looking ahead to 2026, the company is focused on aggressive growth in its core US market, continued innovation, and operational excellence. Oneview expects to benefit from the full-year impact of recent client wins and expansions, as well as the official launch of Ovie. The CEO expressed confidence in Oneview's strategic direction and thanked shareholders, the board, partners, and the Oneview team for their support and contributions.

Oneview expects its operating cash outflows to moderate in 2026 compared to 2025, due to increasing cash receipts and a leaner cost base following reorganization efforts in 2025.

Oneview's primary growth engine in 2026 will be the United States, supported by opportunities in the Middle East. The company carries strong sales momentum into 2026, with an extensive pipeline of potential deals in the US. Oneview also anticipates additional sales through its partnership with Baxter. The company remains focused on converting its deployment pipeline into live, revenue-generating endpoints as quickly as possible.